Literature DB >> 29086801

46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study.

Eric Y Yen1, Magda Shaheen1, Jennifer M P Woo1, Neil Mercer1, Ning Li1, Deborah K McCurdy1, Arun Karlamangla1, Ram R Singh1.   

Abstract

BACKGROUND: No large population-based studies have been done on systemic lupus erythematosus (SLE) mortality trends in the United States.
OBJECTIVE: To identify secular trends and population characteristics associated with SLE mortality.
DESIGN: Population-based study using a national mortality database and census data.
SETTING: United States. PARTICIPANTS: All U.S. residents, 1968 through 2013. MEASUREMENTS: Joinpoint trend analysis of annual age-standardized mortality rates (ASMRs) for SLE and non-SLE causes by sex, race/ethnicity, and geographic region; multiple logistic regression analysis to determine independent associations of demographic variables and period with SLE mortality.
RESULTS: There were 50 249 SLE deaths and 100 851 288 non-SLE deaths from 1968 through 2013. Over this period, the SLE ASMR decreased less than the non-SLE ASMR, with a 34.6% cumulative increase in the ratio of the former to the latter. The non-SLE ASMR decreased every year starting in 1968, whereas the SLE ASMR decreased between 1968 and 1975, increased between 1975 and 1999, and decreased thereafter. Similar patterns were seen in both sexes, among black persons, and in the South. However, statistically significant increases in the SLE ASMR did not occur among white persons over the 46-year period. Females, black persons, and residents of the South had higher SLE ASMRs and larger cumulative increases in the ratio of the SLE to the non-SLE ASMR (31.4%, 62.5%, and 58.6%, respectively) than males, other racial/ethnic groups, and residents of other regions, respectively. Multiple logistic regression showed independent associations of sex, race, and region with SLE mortality risk and revealed significant racial/ethnic differences in associations of SLE mortality with sex and region. LIMITATIONS: Underreporting of SLE on death certificates may have resulted in underestimates of SLE ASMRs. Accuracy of coding on death certificates is difficult to ascertain.
CONCLUSION: Rates of SLE mortality have decreased since 1968 but remain high relative to non-SLE mortality, and significant sex, racial, and regional disparities persist. PRIMARY FUNDING SOURCE: None.

Entities:  

Mesh:

Year:  2017        PMID: 29086801      PMCID: PMC6188647          DOI: 10.7326/M17-0102

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  32 in total

1.  Cyclophosphamide in lupus nephritis: a controlled trial.

Authors:  A D Steinberg; H B Kaltreider; P J Staples; E J Goetzl; N Talal; J L Decker
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

2.  Azathioprine in the treatment of systemic lupus erythematosus. A controlled study.

Authors:  M Sztejnbok; A Stewart; H Diamond; D Kaplan
Journal:  Arthritis Rheum       Date:  1971 Sep-Oct

3.  Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.

Authors:  D T Felson; J Anderson
Journal:  N Engl J Med       Date:  1984-12-13       Impact factor: 91.245

4.  Systemic lupus erythematosus in northwestern Spain: a 20-year epidemiologic study.

Authors:  Maria D Alonso; Javier Llorca; Francisco Martinez-Vazquez; Jose A Miranda-Filloy; Teresa Diaz de Teran; Trinidad Dierssen; Tomas R Vazquez-Rodriguez; Ines Gomez-Acebo; Ricardo Blanco; Miguel A Gonzalez-Gay
Journal:  Medicine (Baltimore)       Date:  2011-09       Impact factor: 1.889

5.  Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus.

Authors:  Murray B Urowitz; Dafna D Gladman; Brian D M Tom; Dominique Ibañez; Vernon T Farewell
Journal:  J Rheumatol       Date:  2008-09-15       Impact factor: 4.666

6.  Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.

Authors:  A N Malaviya; R R Singh; R Sindhwani; Y N Singh; R K Ahujà; U N Bhuyan; S D Khare; A Kumar; R Malaviya; P C Negi
Journal:  Indian J Med Res       Date:  1992-04       Impact factor: 2.375

7.  Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies.

Authors:  Marko Yurkovich; Kateryna Vostretsova; Wenjia Chen; J Antonio Aviña-Zubieta
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-04       Impact factor: 4.794

8.  Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.

Authors:  K M Uramoto; C J Michet; J Thumboo; J Sunku; W M O'Fallon; S E Gabriel
Journal:  Arthritis Rheum       Date:  1999-01

9.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

10.  Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis.

Authors:  Y H Lee; S J Choi; J D Ji; G G Song
Journal:  Lupus       Date:  2016-01-24       Impact factor: 2.911

View more
  40 in total

Review 1.  Epidemiology of systemic lupus erythematosus: an update.

Authors:  George Stojan; Michelle Petri
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

2.  Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.

Authors:  Titilola Falasinnu; Marios Rossides; Yashaar Chaichian; Julia F Simard
Journal:  Public Health Rep       Date:  2018-06-21       Impact factor: 2.792

3.  Brief Report: Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015.

Authors:  Eric Y Yen; Ram R Singh
Journal:  Arthritis Rheumatol       Date:  2018-06-27       Impact factor: 10.995

4.  Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.

Authors:  James B Wetmore; Yi Peng; David T Gilbertson; Jiannong Liu
Journal:  Am J Cardiol       Date:  2018-11-24       Impact factor: 2.778

5.  Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.

Authors:  David H Chae; Connor D Martz; Thomas E Fuller-Rowell; Erica C Spears; Tianqi Tenchi Gao Smith; Evelyn A Hunter; Cristina Drenkard; S Sam Lim
Journal:  Am J Epidemiol       Date:  2019-08-01       Impact factor: 4.897

6.  Burden of Systemic Lupus Erythematosus on Work Productivity and Daily Living Activity: A Cross-Sectional Study Among Malaysian Multi-Ethnic Cohort.

Authors:  Fakhriah Abu Bakar; Syahrul Sazliyana Shaharir; Rozita Mohd; Mohd Shahrir Mohamed Said; Sakthiswary Rajalingham; Kong Wei Yen
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

Review 7.  Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.

Authors:  Huaxia Yang; Huazhen Liu; Ziyue Zhou; Lidan Zhao; Yunyun Fei; Hua Chen; Fengchun Zhang; Xuan Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-07       Impact factor: 8.667

Review 8.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

9.  SLE mortality remains disproportionately high, despite improvements over the last decade.

Authors:  R R Singh; E Y Yen
Journal:  Lupus       Date:  2018-07-17       Impact factor: 2.911

10.  The Care-coordination Approach to Learning Lupus Self-Management: a patient navigator intervention for systemic lupus inpatients.

Authors:  Ashley A White; Aissatou Ba; Trevor Daniel Faith; Viswanathan Ramakrishnan; Clara L Dismuke-Greer; Jim C Oates; Edith Marie Williams
Journal:  Lupus Sci Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.